JSB Market Research: Nuclear Medicine Market and Radiopharmaceuticals - Global Trends & Forecast to 2017

1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions
2 Summary
(Page No. - 35)
3 Market Overview (Page No. - 40)
3.1 Definition Of Radiopharmaceuticals
3.2 Evolution
3.3 Market Segmentation
3.3.1 Radiopharmaceuticals
3.3.2 Stable Isotopes
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Increasing Incidence Of Cancer And Cardiac Ailments Boosts The Demand For
Radiopharmaceuticals
3.4.1.2 Increasing Use Of Spect And Pet Scans Results In Rise Of Radiopharmaceutical Usage
3.4.1.3 Rising Awareness Of Radiopharmaceuticals To Spur Growth
3.4.1.4 Ready Availability Of Radiopharmaceuticals From Cyclotrons To Goad The Growth
3.4.2 Restraints
3.4.2.1 Shorter Half-Life Of Radiopharmaceuticals Restricts Its Usage
3.4.2.2 High Capital To Limit The Buying Of Scanners
3.4.2.3 Stringent Regulatory Guidelines And Gmp To Negatively Impact Growth
3.4.2.4 Competition From Conventional Diagnostic Procedures
3.4.3 Opportunities
3.4.3.1 Potential Radioisotopes In The Pipeline
3.4.3.2 High Demand In Emerging Countries
3.4.3.3 Alpha Radio Immunotherapy-Based Targeted Cancer Treatment
3.4.3.4 Alternative Diagnostic Radiopharmaceutical Solutions
3.4.3.5 Cyclotron Based Production
3.4.3.6 Neurological Applications
3.4.4 Threat
3.4.4.1 Shutdown Of Nuclear Reactors To Impact Production Of Radioisotopes
3.5 Winning Imperatives
3.5.1 Investments On New Radioisotopes And Novel Applications
3.5.2 Shift Towards Leu-Based Mo-99 Production
3.6 Burning Issues
3.6.1 High Cost Of Pet Cameras
3.6.2 Shortage In Supply Of Technetium-99m
3.7 Market Share Analysis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/